Protara Therapeutics, Inc.
TARA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001359931
No open-market purchases or sales by Protara Therapeutics, Inc. insiders were filed in the last 90 days; 119 institutions reported holding it in 13F filings for Q2 2026, worth $176.0M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Protara Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 114
- +10 vs. Q4 2025
- Shares held
- 45.6M
- +8.13M (+21.7%) vs. Q4 2025
- Total value
- $237.4M
- +$37.9M (+19.0%) vs. Q4 2025
- New holders
- 31
- 48 more added
- Sold out
- 21
- 23 more reduced
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TARA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 119 | $176.0M |
| Q1 2026 | 114 | $237.4M |
| Q4 2025 | 105 | $212.3M |
| Q3 2025 | 81 | $114.0M |
| Q2 2025 | 76 | $90.1M |
| Q1 2025 | 59 | $123.8M |
| Q4 2024 | 60 | $156.6M |
| Q3 2024 | 35 | $19.1M |
| Q2 2024 | 38 | $22.2M |
| Q1 2024 | 34 | $18.3M |
| Q4 2023 | 30 | $8.17M |
| Q3 2023 | 31 | $8.55M |
| Q2 2023 | 29 | $12.3M |
| Q1 2023 | 29 | $16.9M |
| Q4 2022 | 30 | $14.7M |
| Q3 2022 | 31 | $16.7M |
| Q2 2022 | 33 | $18.4M |
| Q1 2022 | 35 | $33.2M |
| Q4 2021 | 38 | $46.5M |
| Q3 2021 | 36 | $43.7M |
| Q2 2021 | 40 | $69.3M |
| Q1 2021 | 50 | $134.0M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Protara Therapeutics, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 1,152,714 | $6.01M | 0.01% | +1,124,607+4,001.2% | Added |
| Geode Capital Management, LLC | 1,177,200 | $6.13M | 0.00% | +360,004+44.1% | Added |
| 5AM Venture Management, LLC | 1,369,782 | $7.14M | 1.98% | 00.0% | Unchanged |
| UBS Group AG | 1,402,413 | $7.31M | 0.00% | +186,876+15.4% | Added |
| AIGH Capital Management LLC | 1,622,733 | $8.45M | 1.73% | +1,622,733 | New |
| Integral Health Asset Management, LLC | 1,750,000 | $9.12M | 0.48% | −500,000−22.2% | Reduced |
| Acorn Capital Advisors, LLC | 1,752,115 | $9.13M | 2.59% | 00.0% | Unchanged |
| Sio Capital Management, LLC | 1,969,839 | $10.3M | 1.48% | +254,445+14.8% | Added |
| Vanguard Capital Management LLC | 2,119,018 | $11.0M | 0.00% | +2,119,018 | New |
| Blackstone Group Inc. | 2,265,514 | $11.8M | 0.05% | +355,852+18.6% | Added |
| Millennium Management LLC | 2,831,208 | $14.8M | 0.01% | +2,077,906+275.8% | Added |
| Velan Capital Investment Management LP | 2,834,652 | $14.8M | 9.25% | 00.0% | Unchanged |
| BlackRock, Inc. | 3,394,968 | $17.7M | 0.00% | +986,100+40.9% | Added |
| Janus Henderson Group PLC | 5,207,011 | $27.2M | 0.01% | +65,395+1.3% | Added |
| Driehaus Capital Management LLC | 0 | $0 | 0.00% | −1,259,427−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −1,043,478−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −754,626−100.0% | Sold out |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −650,000−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −156,135−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −153,985−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −125,000−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −103,611−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −63,079−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −52,332−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −43,796−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −36,260−100.0% | Sold out |
| Longaeva Partners L.P. | 0 | $0 | 0.00% | −33,857−100.0% | Sold out |
| Quadrature Capital Ltd | 0 | $0 | 0.00% | −24,184−100.0% | Sold out |
| Campbell & CO Investment Adviser LLC | 0 | $0 | 0.00% | −20,551−100.0% | Sold out |
| Scientech Research LLC | 0 | $0 | 0.00% | −17,215−100.0% | Sold out |
| Empery Asset Management, LP | 0 | $0 | 0.00% | −12,832−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −12,692−100.0% | Sold out |
| Persistent Asset Partners Ltd | 0 | $0 | 0.00% | −10,733−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −1,108−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |